Rheumatoid arthritis is a chronic disease that affects connective tissues, primarily small joints, and this occurs symmetrically (for example, the left and right elbow joints). Rheumatoid arthritis is accompanied by inflammation of internal organs. An important stage of arthritis treatment in Israel is the prevention of osteoporosis.
Causes
Rheumatoid arthritis is a disease with unknown etiology. Possible causes of arthritis development include viral and bacterial diseases, injuries, allergies, and hereditary factors.
Symptoms of Rheumatoid Polyarthritis
Common symptoms of this disease include rapid fatigue, slight fever, and enlarged lymph nodes. As mentioned earlier, joint involvement occurs symmetrically, which is a characteristic of rheumatoid arthritis. The disease may present with conditions such as: stiffness of joints in the morning, joint deformities, rheumatoid foot (deformation of the first toe), and the metacarpophalangeal joint (disruption of swallowing function, hoarseness). Arthritis is characterized by damage to the tissues surrounding the joints, which manifests as swelling and puffiness. Arthritis may have systemic manifestations in the form of anemia and a decrease in platelet count due to liver dysfunction.
Diagnosis of Rheumatoid Polyarthritis in Israel
The diagnosis of rheumatoid arthritis in Israel begins with a biochemical blood test. The focus of the studies is on anemia, ESR indicators, and C-reactive protein levels. A urine test is conducted to check for the presence of protein. During the diagnosis, kidney function is assessed. To identify joint changes, X-rays are performed.
Treatment of Rheumatoid Polyarthritis in Israel
Treatment in Israel is comprehensive and includes medication therapy and additional therapeutic measures. The treatment course consists of non-steroidal anti-inflammatory drugs (meloxicam, nimesulide), disease-modifying agents (Enbrel, azathioprine, leflunomide, cyclophosphamide, and others), and glucocorticoids. Disease-modifying therapy is selected for a period not exceeding six months. If the medications are ineffective for 1.5-3 months, they are replaced. Hormonal medications are used when there is a high degree of inflammatory activity and low effectiveness of anti-inflammatory drugs. Additional therapy in the absence of effect from standard treatment includes plasma exchange and lymphocyte apheresis.